NovoCure Limited (NVCR) Stock Analysis
Last updated Sep 8, 2026
Health Check
Last analyzed Sep 7, 2026
- Financial Health 40
- Profitability 40
- Business Quality 75
- Balance Sheet 45
- Cash Flow 25
Why this rating?
Health 45/100 — Speculative
Entry timing is weak right now. Quality may be fine; the setup is not.
Company overview
NovoCure Limited (NVCR) is a Medical Devices company in the Healthcare sector. Compound Radar rates NovoCure Limited 45/100 (Speculative) due to high business quality, strong revenue growth, and elevated leverage.
Investment profile
- Quality High
- Growth Strong
- Balance Sheet Stretched
Financial highlights
Valuation
- Forward P/E -20.64
- EV/Revenue 2.69
Profitability
- Revenue Growth 15.6%
- Gross Margin 76.4%
- Operating Margin -5.8%
- Net Margin -21.2%
- ROE -43.2%
Financial strength
- Cash $440.56M
- Debt $233.42M
- Net Cash $207.14M
- Free Cash Flow $-75.68M
- Current Ratio 2.89
Similar companies
Peers in Medical Devices, ranked by Financial Health.
Latest quoted price for the name. Helps anchor the setup in today’s market level.
Health Entry- Globus Medical, Inc. Medical Devices GMED$75.04 82 Health 82 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Good Entry Good EntryA usable setup — not as clean as Strong Entry, but timing is not mixed or weak.
- Boston Scientific Corporation Medical Devices BSX$44.98 80 Health 80 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Edwards Lifesciences Corporation Medical Devices EW$86.72 80 Health 80 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Insulet Corporation Medical Devices PODD$142.28 80 Health 80 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- TransMedics Group, Inc. Medical Devices TMDX$88.27 77 Health 77 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- DexCom, Inc. Medical Devices DXCM$84.53 76 Health 76 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Haemonetics Corporation Medical Devices HAE$102.84 74 Health 74 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
- Inspire Medical Systems, Inc. Medical Devices INSP$62.14 73 Health 73 / 100
Strong business quality across profitability, growth, balance sheet, and cash flow.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
FAQ
How Compound Radar scores and tracks NovoCure Limited (NVCR).